These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37505730)

  • 21. Administration Routes of Polyethylenimine-Coated PLGA Nanoparticles Encapsulating Angelica Sinensis Polysaccharide Vaccine Delivery System Affect Immune Responses.
    Gu P; Zhang Y; Cai G; Liu Z; Hu Y; Liu J; Wang D
    Mol Pharm; 2021 Jun; 18(6):2274-2284. PubMed ID: 33926191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
    Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
    Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-dose Ag85B-ESAT6-loaded poly(lactic-
    Malik A; Gupta M; Mani R; Bhatnagar R
    Int J Nanomedicine; 2019; 14():3129-3143. PubMed ID: 31118627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium perfringens epsilon toxin: the third most potent bacterial toxin known.
    Alves GG; Machado de Ávila RA; Chávez-Olórtegui CD; Lobato FC
    Anaerobe; 2014 Dec; 30():102-7. PubMed ID: 25234332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against
    Du X; Xue J; Jiang M; Lin S; Huang Y; Deng K; Shu L; Xu H; Li Z; Yao J; Chen S; Shen Z; Feng G
    Int J Nanomedicine; 2021; 16():1819-1836. PubMed ID: 33707942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Immunoenhancement Effects of Polyethylenimine-Modified Chinese Yam Polysaccharide-Encapsulated PLGA Nanoparticles as an Adjuvant.
    Zhang Y; Gu P; Wusiman A; Xu S; Ni H; Qiu T; Liu Z; Hu Y; Liu J; Wang D
    Int J Nanomedicine; 2020; 15():5527-5543. PubMed ID: 32848386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants.
    Lobato FC; Lima CG; Assis RA; Pires PS; Silva RO; Salvarani FM; Carmo AO; Contigli C; Kalapothakis E
    Vaccine; 2010 Aug; 28(38):6125-7. PubMed ID: 20670910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant to enhance immune responses.
    Gu P; Wusiman A; Wang S; Zhang Y; Liu Z; Hu Y; Liu J; Wang D
    Carbohydr Polym; 2019 Nov; 223():115128. PubMed ID: 31427012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning and expression of epsilon toxin from Clostridium perfringens type D and tests of animal immunization.
    Souza AM; Reis JK; Assis RA; Horta CC; Siqueira FF; Facchin S; Alvarenga ER; Castro CS; Salvarani FM; Silva RO; Pires PS; Contigli C; Lobato FC; Kalapothakis E
    Genet Mol Res; 2010 Feb; 9(1):266-76. PubMed ID: 20198582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epsilon toxin from Clostridium perfringens induces toxic effects on skin tissues and HaCaT and human epidermal keratinocytes.
    Geng Z; Kang L; Huang J; Gao S; Wang J; Yuan Y; Li Y; Wang J; Xin W
    Toxicon; 2021 Jul; 198():102-110. PubMed ID: 33965432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rational Design of PLGA Nanoparticle Vaccine Delivery Systems To Improve Immune Responses.
    Gu P; Wusiman A; Zhang Y; Liu Z; Bo R; Hu Y; Liu J; Wang D
    Mol Pharm; 2019 Dec; 16(12):5000-5012. PubMed ID: 31621331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and protective efficacy of an inactivated Newcastle disease virus vaccine encapsulated in poly-(lactic-co-glycolic acid) nanoparticles.
    Ananda Kumar BS; Panickan S; Bindu S; Kumar V; Ramakrishnan S; Saxena S; Shrivastava S; Dandapat S
    Poult Sci; 2023 Jun; 102(6):102679. PubMed ID: 37116285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced immunogenicity of foot and mouth disease DNA vaccine delivered by PLGA nanoparticles combined with cytokine adjuvants.
    Yang Y; Teng Z; Lu Y; Luo X; Mu S; Ru J; Zhao X; Guo H; Ran X; Wen X; Sun S
    Res Vet Sci; 2021 May; 136():89-96. PubMed ID: 33592449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epsilon toxin is essential for the virulence of Clostridium perfringens type D infection in sheep, goats, and mice.
    Garcia JP; Adams V; Beingesser J; Hughes ML; Poon R; Lyras D; Hill A; McClane BA; Rood JI; Uzal FA
    Infect Immun; 2013 Jul; 81(7):2405-14. PubMed ID: 23630957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of peptide based epsilon toxin vaccine by covalent anchoring to tetanus toxoid.
    Kaushik H; Dixit A; Garg LC
    Anaerobe; 2018 Oct; 53():50-55. PubMed ID: 29920342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
    Singh D; Somani VK; Aggarwal S; Bhatnagar R
    Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dual-delivery platform for vaccination using antigen-loaded nanoparticles in dissolving microneedles.
    Braz Gomes K; D'Souza B; Vijayanand S; Menon I; D'Souza MJ
    Int J Pharm; 2022 Feb; 613():121393. PubMed ID: 34929312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enterotoxemia produced by lambda toxin-positive
    Acevedo HD; Schlesinger MS; Streitenberger N; Henderson E; Asin J; Beingesser J; Uzal FA
    J Vet Diagn Invest; 2023 Jul; 35(4):448-451. PubMed ID: 37212504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DEC-205 receptor targeted poly(lactic-co-glycolic acid) nanoparticles containing Eucommia ulmoides polysaccharide enhances the immune response of foot-and-mouth disease vaccine in mice.
    Feng Y; Fan J; Wu D; Liu Q; Li H; Zhang X; Li S; Tang F; Liu Z; Zhang L; Feng H
    Int J Biol Macromol; 2023 Feb; 227():576-589. PubMed ID: 36549613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of a recombinant Lactobacillus casei, surface-expressed H
    Alimolaei M; Golchin M; Baluch-Akbari A
    Toxicon; 2021 Sep; 200():173-179. PubMed ID: 34324946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.